239 related articles for article (PubMed ID: 33042154)
1. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
Front Immunol; 2020; 11():573677. PubMed ID: 33042154
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.
Seliga A; Lee MH; Fernandes NC; Zuluaga-Ramirez V; Didukh M; Persidsky Y; Potula R; Gallucci S; Sriram U
Front Immunol; 2018; 9():156. PubMed ID: 29456540
[TBL] [Abstract][Full Text] [Related]
4. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL
Soto M; Delatorre N; Hurst C; Rodgers KE
Front Immunol; 2020; 11():1572. PubMed ID: 32793221
[TBL] [Abstract][Full Text] [Related]
6. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
7. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.
De Albuquerque DA; Saxena V; Adams DE; Boivin GP; Brunner HI; Witte DP; Singh RR
Kidney Int; 2004 Mar; 65(3):846-59. PubMed ID: 14871404
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
9. Ectopic CD4
Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
[TBL] [Abstract][Full Text] [Related]
10. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice.
Qiao X; Wang H; Lu L; Chen J; Cheng Q; Guo M; Hou Y; Dou H
J Neuroimmunol; 2021 Aug; 357():577620. PubMed ID: 34062352
[TBL] [Abstract][Full Text] [Related]
12. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
[TBL] [Abstract][Full Text] [Related]
13. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
14. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
[TBL] [Abstract][Full Text] [Related]
15. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
[TBL] [Abstract][Full Text] [Related]
16. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
Huang MW; Stock AD; Putterman C
Front Immunol; 2021; 12():763065. PubMed ID: 34868008
[TBL] [Abstract][Full Text] [Related]
17. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of NF-κB Kinase Subunit ε Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation.
Karino K; Kono M; Takeyama S; Kudo Y; Kanda M; Abe N; Aso K; Fujieda Y; Kato M; Oku K; Amengual O; Atsumi T
Arthritis Rheumatol; 2023 Mar; 75(3):411-423. PubMed ID: 36098515
[TBL] [Abstract][Full Text] [Related]
19. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
Front Immunol; 2020; 11():1476. PubMed ID: 32765512
[No Abstract] [Full Text] [Related]
20. Microglia-dependent synapse loss in type I interferon-mediated lupus.
Bialas AR; Presumey J; Das A; van der Poel CE; Lapchak PH; Mesin L; Victora G; Tsokos GC; Mawrin C; Herbst R; Carroll MC
Nature; 2017 Jun; 546(7659):539-543. PubMed ID: 28614301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
